Detalhe da pesquisa
1.
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin.
Immunity
; 51(2): 398-410.e5, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350180
2.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921449
3.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709074
4.
A Monoclonal Antibody for Malaria Prevention.
N Engl J Med
; 385(9): 803-814, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379916
5.
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Lancet
; 393(10174): 889-898, 2019 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686586
6.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med
; 376(10): 928-938, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426834
7.
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial.
JAMA
; 323(14): 1369-1377, 2020 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286643
8.
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
PLoS Med
; 15(1): e1002493, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364886
9.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines
; 9(1): 67, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553525
10.
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587079
11.
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination.
NPJ Vaccines
; 8(1): 39, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922512
12.
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals.
Vaccine
; 41(42): 6146-6149, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690874
13.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708738
14.
HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity.
Science
; 382(6676): 1270-1276, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096385
15.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075129
16.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544326
17.
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.
Lancet Infect Dis
; 22(8): 1210-1220, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568049
18.
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Nat Med
; 28(2): 383-391, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115706
19.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Nat Med
; 28(5): 1022-1030, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411076
20.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35783486